Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name

Get basic information on what anemia is, what causes it, why it is of special concern to HIV+ women, and how it is diagnosed and treated.

Learn what parents and providers need to know about HIV risk factors specific to teens and the importance of talking to your teen about HIV.

Learn about substance abuse, dependence, and addiction, how they affect living with HIV, how to know if you have a problem, and what to do.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>